MDMA and alcohol effects, combined and alone, on objective and subjective measures of actual driving performance and psychomotor function

Psychopharmacology

Volumn 187, Issue 4, 2006, Pages 467-475

  Kuypers, K P C ^a   Samyn, N ^b   Ramaekers, J G ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b National Institute of Criminalistics and Criminology   (Belgium)

Author keywords

Actual driving performance; Alcohol; MDMA

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL;

ADDICTION RESEARCH CENTER INVENTORY; ADULT; ARTICLE; BREAK REACTION TIME; CAR; CAR FOLLOWING TEST; COHERENCE; CRITICAL TRACKING TASK; DRIVING ABILITY; FEMALE; HUMAN; HUMAN EXPERIMENT; LABORATORY TEST; LANGUAGE ABILITY; MALE; MENTAL FUNCTION; NORMAL HUMAN; OBJECT MOVEMENT ESTIMATION TASK; PARAMETER; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; QUESTIONNAIRE; RESPONSE TIME; ROAD TRACKING TEST; STANDARD DEVIATION OF LATERAL POSITION; TASK PERFORMANCE; VELOCITY;

ADULT; ATTENTION; AUTOMOBILE DRIVING; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; ETHANOL; HALLUCINOGENS; HUMANS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PSYCHOMOTOR PERFORMANCE; QUESTIONNAIRES; REACTION TIME; REFERENCE VALUES; TIME FACTORS;

EID: 33746911657     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-006-0434-z     Document Type: Article

References (26)

1. Barrett SP, Gross SR, Garand I, Pihl RO (2005) Patterns of simultaneous polysubstance use in Canadian rave attendees. Subst Use Misuse 40(9-10): 1525-1537
2. Brookhuis KA, de Waard D, Mulder B (1994) Measuring driving performance by car-following in traffic. Ergonomics 37:427-434
3. Brookhuis KA, De Waard D, Samyn N (2004) Effects of MDMA (ecstasy), and multiple drugs use on (simulated) driving performance and traffic safety. Psychopharmacology 173:440-445
4. Carmen del Rio M, Gomez J, Sancho M, Alvarez FJ (2002) Alcohol, illicit drugs and medicinal drugs in fatally injured drivers in Spain between 1991 and 2000. Forensic Sci Int 127:63-70
5. de la Torre R, Farre M, Ortuno J, Mas M, Brenneisen R, Roset PN, Sequra J, Cami J (2000) Non-linear pharmacokinetics of MDMA ('ecstasy') in humans. Br J Clin Pharmacol 49:104-109
6. de la Torre R, Farre M, Roset PN, Pizarro N, Abanades S, Segura M, Segura J, Cami J (2004) Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition. Ther Drug Monit 26:137-144
7. de Wit H, Crean J, Richards JB (2000) Effects of D-amphetamine and ethanol on a measure of behavioral inhibition in humans. Behav Neurosci 114:830-837
8. Haertzen CA (1965) Addiction Research Center Inventory (ARCI): development of a general drug estimation scale. J Nerv Ment Dis 141:300-307
9. Henry JA (1992) Ecstasy and the dance of death. BMJ 305:5-6
10. Henry JA, Jeffreys KJ, Dawling S (1992) Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy"). Lancet 340:384-387
11. Hernandez-Lopez C, Farre M, Roset PN, Menoyo E, Pizarro N, Ortuno J, Torrens M, Cami J, de la Torre R (2002) 3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics. J Pharmacol Exp Ther 300:236-244
12. Jex HR, McDonnell JD, Phatak AV (1966) A "critical" tracking task for man-machine research related to the operator's effective delay time. I. Theory and experiments with a first-order divergent controlled element. NASA CR-616. NASA Contract Rep NASA CR: 1-105
13. Lamers CT, Ramaekers JG, Muntjewerff ND, Sikkema KL, Samyn N, Read NL, Brookhuis KA, Riedel WJ (2003) Dissociable effects of a single dose of ecstasy (MDMA) on psychomotor skills and attentional performance. J Psychopharmacol (Oxford, England) 17:379-387
14. Logan BK, Couper FJ (2001) 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) and driving impairment. J Forensic Sci 46:1426-1433
15. Mas M, Farre M, de la Torre R, Roset PN, Ortuno J, Segura J, Cami J (1999) Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans. J Pharmacol Exp Ther 290:136-45
16. O'Hanlon JF (1984) Driving performance under the influence of drugs: rationale for, and application of, a new test. BJCP Br J Clin Pharmacol 18(Suppl 1):121s-129s
17. Parrott AC (2004) Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity. Psychopharmacology 173:234-241
18. Ramaekers JG, Kuypers KP (2006) Acute effects of 3,4- methylenedioxymethamphetamine (MDMA) on behavioral measures of impulsivity: alone and in combination with alcohol. Neuropsychopharmacology Official Publication of the American College of Neuropsychopharmacology 31:1048-1055
19. Ramaekers JG, Kuypers KPC, Samyn N (2006) Stimulant effects of MDMA 75 mg and methylphenidate 20 mg on actual driving during intoxication and withdrawal. Addiction (in press)
20. Ramaekers JG, Robbe HWJ, O'Hanlon JF (2000) Marijuana, alcohol and actual driving performance. Hum Psychopharmacol 15:551-558
21. Read N, Ward N, Parkes A (2000) The role of dynamic tests in assessing the fitness to drive of healthy and cognitively impaired elderly. J Traffic Med 28:34S-35S
22. Riley SC, James C, Gregory D, Dingle H, Cadger M (2001) Patterns of recreational drug use at dance events in Edinburgh, Scotland. Addiction (Abingdon, England) 96:1035-1047
23. Schifano F (1995) Dangerous driving and MDMA ("ecstasy") abuse. Journal Serotonin Res 1:53-57
24. Topp L, Hando J, Dillon P, Roche A, Solowij N (1999) Ecstasy use in Australia: patterns of use and associated harm. Drug Alcohol Depend 55:105-115
25. World Medical Organization. Declaration of Helsinki. Br Med J (7 December) 1996;313(7070):1448-1499
26. Zijlstra F (1993) Efficiency in work behavior. A design approach for modern tools. University of Technology, Delft, The Netherlands